South Korea Uterine Cancer Market Size & Outlook, 2025-2033


South Korea Uterine Cancer Market Insights

  • According to Reed Intelligence analysis, the South Korea Uterine Cancer Market size was USD 51.89 Million in 2024 and is projected to reach USD 82.3 Million by 2033.
  • The South Korea market is projected to grow at a CAGR of 5.29% between 2026 and 2033.
  • By segment, Endometrial Adenocarcinoma emerged as the largest By Type in terms of market size in 2024.
  • Uterine Sarcoma is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • As of 2024, South Korea held 0.83% of the global Uterine Cancer Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Uterine Cancer Market.
  • In Asia Pacific, China is expected to lead the regional Uterine Cancer Market size by 2033.
  • South Korea will remain the fastest-growing market in Asia Pacific, reaching USD 82.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 51.89 Million
Market Size In 2033 USD 82.3 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.29% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends